Skip to main content
    S

    Sight Sciences Inc (SGHT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $10.49
    -0.10 (-0.94%)

    Market Cap: $601.92M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Sight Sciences Inc (SGHT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Sight Sciences (SGHT) has a market cap of $601.92M and an enterprise value of $565.55M. It kept -32.13% of revenue as net income over the last 12 months. Its share count is up 5.25% from a year earlier.

    Total Valuation

    Enterprise value is 6.04% below the market cap, as cash exceeds debt.

    Market Cap$601.92M
    Enterprise Value$565.55M
    Latest price (Nov 17, 2026)$10.49

    Key Dates

    The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 2, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.14% in the quarter ended Sep 30, 2026 and grew 4.65% a year over 2 years.

    Shares Outstanding55.13M
    Shares Change (YoY)+5.25%
    Shares Change (QoQ)+1.14%
    Share Count Growth (2Y CAGR)+4.65%

    Valuation Ratios

    Sales and book value multiples are 6.5x and 11.8x. Its year-end P/S ranged from 2.3x to 8.2x from 2021 to 2025.

    P/S Ratio6.5x
    Forward P/S6.5x
    P/B Ratio11.8x

    Valuation history and multiples

    Price Statistics

    The stock is up 47.54% over 52 weeks and trades 15.78% above its 50-day average.

    Beta (1Y)1.44
    52-Week Change+47.54%
    1-Month Change+27.00%
    3-Month Change+23.85%
    6-Month Change+122.25%
    5-Year Change-65.44%
    Total Return (1Y)+47.54%
    Total Return (3Y CAGR)+67.04%
    Total Return (5Y CAGR)-13.09%
    Return vs SPY (1Y)+35.36%
    Max Drawdown (1Y)-61.88%
    Max Drawdown (3Y)-74.85%
    Sharpe Ratio (1Y)0.54
    Correlation with SPY (1Y)0.27
    50-Day Average$9.06
    200-Day Average$6.23
    52-Week Range$3.38 to $11.60
    RSI (14 Days)62.2
    Average Volume (20 Days)405.76K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.04x current liabilities, and total debt is 0.83x shareholder equity.

    Current Ratio5.04x
    Quick Ratio4.72x
    Debt / Equity0.83x
    Interest Coverage-5.06x

    Returns and Efficiency

    Return on invested capital is -28.98% over the last 12 months, against a 5-year average of -38.39%.

    Return on Equity (ROE)-57.79%
    Return on Assets (ROA)-27.06%
    Return on Invested Capital (ROIC)-28.98%
    Return on Capital Employed (ROCE)-30.80%
    ROE (5Y Average)-49.23%
    ROA (5Y Average)-33.13%
    ROIC (5Y Average)-38.39%
    Asset Turnover0.80x
    Inventory Turnover1.78x
    Receivables Turnover7.14x
    Cash Conversion Cycle33 days

    Scores

    SGHT has an Altman Z-Score of 1.71, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score1.71
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $88.39M over the last 12 months is up 16.23% from the 12 months before.

    Revenue$88.39M
    Revenue Growth (YoY)+16.23%
    Gross Profit$77.56M
    Operating Income-$26.10M
    Pretax Income-$28.34M
    Net Income-$28.40M
    EBITDA-$24.75M
    EBIT-$26.13M
    Reported EPS (TTM)-$0.52

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 46.82% of the $104.95M in total assets.

    Cash and Equivalents$77.40M
    Total Debt$41.03M
    Net Cash$36.37M
    Net Cash Per Share$0.66
    Working Capital$81.33M
    Shareholder Equity$49.14M
    Book Value Per Share$0.89
    Total Assets$104.95M
    Total Liabilities$55.81M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $303.00K of capital spending, operating cash flow left -$17.22M of free cash flow.

    Operating Cash Flow-$16.92M
    Capital Expenditures$303.00K
    Free Cash Flow-$17.22M
    FCF Per Share-$0.31
    Depreciation and Amortization$1.38M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -29.52%, against a 5-year average of -80.95%.

    Gross Margin87.74%
    Operating Margin-29.52%
    Pretax Margin-32.06%
    Net Margin-32.13%
    EBITDA Margin-28.00%
    EBIT Margin-29.56%
    FCF Margin-19.49%
    Gross Margin (5Y Average)84.42%
    Operating Margin (5Y Average)-80.95%
    Net Margin (5Y Average)-86.44%

    Growth

    Revenue grew 2.74% a year over 3 years.

    Revenue Growth (3Y CAGR)+2.74%
    Revenue Growth (5Y CAGR)+22.86%
    Book Value Per Share Growth (2Y CAGR)-30.00%
    Tangible Book Per Share Growth (2Y CAGR)-30.00%

    Revenue and profit by year

    Dividends and Yields

    SGHT does not pay a dividend. Its free cash flow yield is -2.98%.

    FCF Yield-2.98%
    Shareholder Yield0.00%

    Peer Position

    Against 12 similar companies, SGHT has the 2nd highest P/S.

    P/S Ratio6.5x vs 3.2x median
    ROIC-28.98% vs -18.01% median
    Revenue Growth (Trailing 4 Quarters, YoY)+16.23% vs +14.20% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 15.88% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+15.88%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SGHT

    What is SGHT's market cap?

    Sight Sciences has a market cap of $601.92M. Its enterprise value, which adds debt and subtracts cash, is $565.55M.

    How many shares of SGHT are outstanding?

    Sight Sciences has 55.13M shares outstanding. The count is up 5.25% from a year earlier.

    Does SGHT pay a dividend?

    No. Sight Sciences does not pay a dividend.

    How much debt does SGHT have?

    Sight Sciences has $41.03M of total debt and $77.40M of cash and equivalents, a net cash position of $36.37M.